HAEM5:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes: Difference between revisions
| [checked revision] | [pending revision] |
Bailey.Glen (talk | contribs) No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} | {{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 9: | Line 10: | ||
Put your text here<span style="color:#0070C0"> ( | Put your text here<span style="color:#0070C0"> (Rolando Garcia, PhD) </span> | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 37: | Line 38: | ||
|+ | |+ | ||
|WHO Essential Criteria (Genetics)* | |WHO Essential Criteria (Genetics)* | ||
| | |Detection of a tyrosine kinase fusion gene not classified under specific unique entities (''PDGFRA, PDGFRB, FGFR1, JAK2, FLT3, ETV6::ABL1''). | ||
|- | |- | ||
|WHO Desirable Criteria (Genetics)* | |WHO Desirable Criteria (Genetics)* | ||
| | |Cytogenetic translocation suggesting a potential involvement of a tyrosine kinase gene, with selection of a FISH break-apart probe or another molecular assay for confirmation. | ||
|- | |- | ||
|Other Classification | |Other Classification | ||
| | |Other desirable criteria: Presence of eosinophilia. | ||
|} | |} | ||
<nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>]. | <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>]. | ||
| Line 294: | Line 295: | ||
<nowiki>*</nowiki>''Citation of this Page'': “Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Myeloid/lymphoid_neoplasms_with_other_tyrosine_kinase_fusion_genes</nowiki>. | <nowiki>*</nowiki>''Citation of this Page'': “Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Myeloid/lymphoid_neoplasms_with_other_tyrosine_kinase_fusion_genes</nowiki>. | ||
[[Category:HAEM5]][[Category:DISEASE]][[Category:Diseases M]] | [[Category:HAEM5]] | ||
[[Category:DISEASE]] | |||
[[Category:Diseases M]] | |||